DISCOUNT-ZERTIFIKAT - NOVO-NORDISK B Share Price

Certificat

DE000HD1Q9C1

Real-time BOERSE MUENCHEN 11:16:45 05/07/2024 pm IST
8.52 EUR +0.12% Intraday chart for DISCOUNT-ZERTIFIKAT - NOVO-NORDISK B
Current month-0.23%
1 month+0.35%
Date Price Change
05/24/05 8.52 +0.12%
04/24/04 8.51 +0.12%
03/24/03 8.5 -0.12%
02/24/02 8.51 -0.12%
01/24/01 8.52 -0.12%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 11:16 pm IST

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer UniCredit UniCredit
WKN HD1Q9C
ISINDE000HD1Q9C1
Date issued 05/01/2024
Cap 650 kr
Last trading day 20/12/2024
Maturity 20/12/2024 (168 Days)
Parity 10 : 1
Emission price 7.93
Emission volume N/A
Payment day 31/12/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 0.000000 %
Sideways yield 0.000000 %
Sideways yield pa 0.000000 %
Outperformance point- kr
Break even 0.000000 €
Highest since issue 8.53
Lowest since issue 7.88
Distance Cap 324 kr
Distance Cap %+33.26%
Max. earning-
Max. earning % 0.000000 %

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
970 DKK
Average target price
952.2 DKK
Spread / Average Target
-1.84%
Consensus